Some ascidians accumulate vanadium in vanadocytes, which are vanadium-containing blood cells, at high levels and with high selectivity. However, the mechanism and physiological significance of vanadium accumulation remain unknown. In this study, we isolated novel proteins with a striking homology to glutathione transferases (GSTs), designated AsGST-I and AsGST-II, from the digestive system of the vanadium-accumulating ascidian Ascidia sydneiensis samea, in which the digestive system is thought to be involved in vanadium uptake. Analysis of recombinant AsGST-I confirmed that AsGST-I has GST activity and forms a dimer, as do other GSTs. In addition, AsGST-I was revealed to have vanadium-binding activity, which has never been reported for GSTs isolated from other organisms. AsGST-I bound about 16 vanadium atoms as either V(IV) or V(V) per dimer, and the apparent dissociation constants for V(IV) and V(V) were 1.8×10 -4 M and 1.2×10 -4 M, respectively. Western blot analysis revealed that AsGSTs were expressed in the digestive system at exceptionally high levels, although they were localized in almost all organs and tissues examined. Considering these results, we postulate that AsGSTs play important roles in vanadium accumulation in the ascidian digestive system.
Introduction
Several species of ascidians, so-called sea squirts, accumulate high levels of vanadium [1, 2] . In the most remarkable case, the cellular vanadium concentration reaches 350 mM, or roughly 10 7 times the concentration in seawater [3] . vanadium-containing cells [4] [5] [6] . Several proteins that are likely involved in the vanadium-accumulation process have already been isolated from the blood cells of the vanadium-rich ascidian A. sydneiensis samea [7] [8] [9] [10] [11] [12] [13] [14] [15] . Of these, two similar proteins, Vanabin1 and Vanabin2, have attracted attention because of their binding ability and selectivity for vanadium [13] [14] [15] . In fact, Vanabin1 and Vanabin2 can bind 10 and 20 V(IV) ions with dissociation constants of 2.1 × 10 -5 M and 2.3 × 10 -5 M, respectively, and the binding with V(IV) is barely inhibited in the presence of magnesium(II) or molybdate(V) ions [15] . Three-dimensional structural analysis using nuclear magnetic resonance (NMR) [16] revealed that Vanabin2 has a novel bow-shaped conformation consisting of four helices connected by nine disulfide bonds, which has no reported structural homologs. V(IV) ions, which are exclusively localized on the same face of the Vanabin2 molecule, are mostly coordinated by amine nitrogens derived from amino acid residues, such as lysines and arginines, as suggested by electron paramagnetic resonance (EPR) results [17] . In addition, two Vanabin homologs, designated Vanabin3 and Vanabin4, were identified from the cytoplasm of vanadocytes in an expressed sequence tag (EST) analysis [18] , and one Vanabin homolog, designated VanabinP, was isolated from the blood plasma (coelomic fluid) using V(IV)-chelating column chromatography [19] . Since all five of these Vanabins are rich in charged residues and have conserved motifs described as the consensus 4 sequence {C}-{X 2-5 }-{C}, they have been placed in the Vanabin family, and should provide a clue to resolving the problem of the selective accumulation of vanadium in ascidians [15, 18, 19] .
The vanadium-accumulating pathway from seawater into the ascidian coelom has never been investigated. Therefore, in this study, we used a V(IV)-chelating column to isolate vanadium-binding proteins from the digestive system, which is thought to be involved in vanadium uptake. Consequently, we isolated and identified two similar, but slightly different, vanadium-binding proteins with striking homology to GSTs, designated AsGST-I and AsGST-II. Like other GSTs, recombinant
AsGST-I formed a dimer, and it not only showed GST activity, but also bound to both V(IV) and V(V). Moreover, using immunoblotting, the expression level of these two AsGSTs in the digestive system was found to be exceptionally high compared to the major organs and tissues. Therefore, AsGSTs may play important roles in vanadium accumulation in the ascidian digestive system.
Materials and methods

Specimens
Specimens of the vanadium-rich ascidian A. sydneiensis samea were collected at the International Coastal Research Center, Ocean Research Institute, The University of Tokyo, Otsuchi, Iwate, Japan. They were maintained in an aquarium that contained circulating natural seawater until use.
Screening vanadium-binding proteins from the ascidian digestive system using V(IV)-chelating column chromatography
To avoid the analytical difficulty that arises from individual differences, especially in the analysis of amino acid sequences, we used one individual per preparation. After the tunic was removed from the ascidian, the body wall was dissected.
The digestive system was separated and washed thoroughly with artificial sea water (ASW; 460 mM NaCl, 9 mM KCl, 32 mM Na 2 SO 4 , 5 mM HEPES, 6 mM NaHCO 3 , pH 7.0) to remove the contents of the digestive system. The specimen was then homogenized in five volumes (ml per gram wet weight) of a homogenizing buffer (200 mM Tris-HCl, 150 mM NaCl, 10 mM EDTA, pH 8.0) using a Teflon homogenizer. The homogenate was centrifuged at 21,600×g for 10 min, and the resulting supernatant was filtered through a cellulose acetate filter (0.45-μm pores) to remove lipidic floats, enclosed in a dialysis tube (6-8,000 Da cut-off), and dialyzed against 100 volumes of a chelating buffer (50 mM Tris-HCl, 500 mM NaCl, 25 mM EDTA, pH 7.2) to remove any metal ions that might interfere with the efficiency of V(IV)-chelating column chromatography. Next, the sample was dialyzed three times in 100 volumes of a binding buffer (20 mM Na 2 HPO 4 , pH 7.2) to remove any EDTA, which might also interfere with chromatography. The protein solution after dialysis was centrifuged at 21,600×g for 10 min and filtered through a cellulose acetate filter (0.45-μm pores) to remove the proteins insolubilized during dialysis.
Chelating Sepharose Fast Flow (Amersham Biosciences) was packed into a polypropylene column (bed size, 1 cm φ × 10 cm). V(IV) ions were chelated to the 6 Sepharose by adding twice the bed volume of 200 mM VOSO 4 ·xH 2 O (Wako). The
Sepharose column was washed with ten bed volumes of distilled water (DW) to remove the unbound excess V(VI) ions, and then equilibrated to the binding buffer.
The prepared protein solution was loaded onto the V(IV)-chelating column. After the application, the Sepharose was washed thoroughly using binding buffer, and the absorbed proteins were eluted using an elution buffer (20 mM Na 2 HPO 4 , 500 mM NaCl, 50 mM EDTA, pH 7.2). Portions of the protein samples from each chromatography step were analyzed using SDS-PAGE on a 12.5% gel.
Determining the N-terminal partial amino acid sequence of vanadium-binding proteins
The chromatography eluent was concentrated by ultrafiltration using a Centriplus YM-3 (Millipore), and the proteins were further separated using reverse-phase high performance liquid chromatography (HPLC). HPLC was performed using a 5C18-AR-300 column (2.0×150 mm, Nacalai Tesque) with water and acetonitrile (both containing 0.1% trifluoroacetic acid). The proteins were eluted at a flow rate of 0.2 ml/min using a linear gradient of 10-70% acetonitrile over 60 min.
Two major protein peaks detected 53 and 55 min after injection were collected, dried under vacuum in a rotatory concentrator, and dissolved in a sample buffer for SDS-PAGE. The samples were subjected to SDS-PAGE on a 12.5% gel and electro-blotted onto polyvinylidene fluoride (PVDF) membrane. The N-terminal partial amino acid sequences of the protein bands corresponding to the two major protein peaks were determined using the Edman degradation method [20] .
Isolation of cDNA clones for the two major vanadium-binding proteins
A degenerate primer was designed based on the sequence common to the 
Expression and purification of recombinant AsGST-I
A specific primer was designed based on the coding region for the C-terminus of the AsGSTs containing the termination codon and a restriction enzyme site for SalI as follows; AsGST/R sal, 5'-GGT CGA CTT ATT CGG TTC TC-3'. Using primers
AsGST/R sal and T3, PCR was performed as described above changing the DNA 8 annealing temperature from 45 to 50°C. The PCR products were sequenced as described above to determine the sequence of the degenerate primer region and the location of the initiation methionine. Based on the sequences, another specific primer was designed to amplify the coding regions of the putative mature AsGSTs, including the initiation methionine, using primer AsGST/R sal; this primer was AsGST/F, 150 mM NaCl, 10 mM EDTA, pH 7.2), and sonicated on ice until clear. The lysate was centrifuged at 10,000×g for 10 min. The resulting supernatant was enclosed in dialysis tubing (6-8,000 Da cut-off) and dialyzed three times against 100 volumes of the binding buffer. The lysate after the dialysis was subjected to V(IV)-chelating column chromatography to purify the AsGST-I recombinant protein as described above. The recombinant protein absorbed to the V(IV)-chelating column was eluted using binding buffer containing 100 mM NaCl. Portions of the protein samples from each purification step were analyzed using SDS-PAGE on a 12.5% gel.
Although the same experiment was performed using E. coli cells bearing the
AsGST-II-expressing vector, little
AsGST-II recombinant protein was obtained because of its low expression level. Therefore, in this study, we used recombinant
AsGST-I as AsGST in all of the following experiments.
Characterization of AsGST-I as a GST enzyme
The GST activity of AsGST-I was determined by using 1-chloro-2,4-dinitrobenzene (CDNB) as a substrate, according to Habig et al. [21] .
The supernatant after the ultrasonication of E. coli cells expressing AsGST-I prepared as described above was diluted 100-fold using a reaction buffer (100 mM K 2 HPO 4 , 1 mM reduced glutathione, 1 mM CDNB, pH 6.5) and the A 340 was monitored. The supernatant prepared from E. coli cells bearing the empty pETBlue1 vector after ultrasonication was used as a control.
Gel filtration was used to investigate whether AsGST-I forms a dimer as do other GSTs. A gel filtration column (bed size, 7 mm φ × 50 cm) filled with Biogel P-60 gel (Medium, Bio-Rad) was equilibrated with the buffer for the Hummel-Dreyer method (HD buffer; 10 mM Tris-HCl, 100 mM NaCl, pH 7.2; see below). For molecular weight calibration, one vial of protein mixture of a low-molecular-weight calibration kit for SDS electrophoresis (Amersham Biosciences) was diluted in 500 μl of HD buffer, and 100 μl of the protein mixture was loaded onto the prepared column and separated at a flow rate of 0.9 ml/h. The eluted fractions were collected every 10 min. Each fraction was analyzed by SDS-PAGE to examine the correlation between molecular weight and the fraction number of eluted peaks. The same experiment was performed using AsGST-I recombinant protein (≈10 μg) to confirm the dimerization of
AsGST-I based on the determined correlation. The protein concentration of each fraction was determined with Bio-Rad reagent (Bio-Rad) to detect the peak fraction.
Vanadium-binding assay of AsGST-I
The vanadium-binding activity of AsGST-I was assayed using the Hummel-Dreyer method [22] as described previously [15] , with some modifications.
All prepared buffers were degassed for 10 min under vacuum before use.
VOSO 4 ·xH 2 O (Wako) was dissolved in water and mixed with an equal molar ratio of iminodiacetic acid (IDA). After the pH was adjusted to 7.0 by adding NaOH, the resulting solution was used as the V(IV) solution. Na 3 VO 4 (Wako) was dissolved in water at 10 mM, and the pH was adjusted to 7.0 by adding HCl and incubating it at 60°C to decompose the yellow decavanadate until it became colorless; this was then used as the V(V) solution.
The AsGST-I recombinant protein purified as described above was concentrated using Centriplus YM-3 and dialyzed once against 100 volumes of the chelating buffer, and three times against 100 volumes of HD buffer. After dialysis, the protein concentration was adjusted to ≈1mg/ml. HD buffer containing twice the concentration of vanadium ions was added to the protein solution such that the vanadium concentration in the protein solution equaled the operating concentration (10-100 μM). 
Preparation of antiserum to AsGST-I
Purified and concentrated AsGST-I recombinant protein (≈100 μg) in 500 μl of phosphate buffered saline (PBS; 140 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , pH 7.3) was mixed with an equal volume of complete Freund's adjuvant and injected into a male Wistar rat (10.0 weeks old, 350 g). Two weeks after the first injection, a second injection was given using incomplete Freund's adjuvant instead of complete adjuvant. Three additional injections using incomplete Freund's adjuvant were given at 2-week intervals. The rat was euthanized 1 week after the last injection, and the blood was collected, incubated at 37°C for 1 h, and then kept at 4°C for 2 days.
The blood was then centrifuged at 1,500×g for 5 min and the resulting supernatant was filtered through a cellulose acetate filter (0.45-μm pores). The prepared serum was used as antiserum to AsGST-I.
Localization analysis of AsGSTs using antiserum to AsGST-I
Using antiserum to AsGST-I, an immunoblot analysis was performed to examine the localization of the AsGSTs. An individual ascidian was dissected into four components: the digestive system, body wall, endostyle, and branchial sac.
Blood cells were collected from several individual ascidians, as described previously [13] . Each specimen was homogenized as described above. Each homogenate mixed with sample buffer for SDS-PAGE was fractionated using SDS-PAGE on a 12.5% gel. The purified AsGST-I recombinant protein was also loaded on the gel as 
Results
Isolation and identification of novel vanadium-binding proteins from the ascidian digestive system
To search for factors involved in vanadium accumulation of ascidians, we attempted to isolate novel vanadium-binding proteins from the digestive system, which is thought to be involved in vanadium uptake. Soluble proteins prepared from the digestive system of an individual vanadium-rich ascidian, A. sydneiensis samea, were separated using a V(IV)-chelating column (Fig.1) . V(IV) is one of the assumed chemical forms of vanadium ingested through the digestive system. Another chemical form, V(V), could not be used for a chelating column because of its low affinity for the column. As a result, several proteins were identified in the vanadium-absorbed fraction (Fig. 1A, lane 5) . The most strongly expressed protein in the digestive system comprised almost the entire vanadium-absorbed fraction (Fig.   1A, arrowhead) . For further separation, the vanadium-absorbed fraction was applied to reverse-phase HPLC (Fig. 1B) . After each of the two major peaks detected 53 and 55 min after injection was confirmed to be a single band (Fig. 1B) , the N-terminal partial amino acid sequence of each peak was determined. The two sequences were almost identical, except for the ninth residue (Fig. 1C) . The leucine in the protein from peak 1 was replaced by methionine in peak 2 (Fig. 1C, open letters) .
Using a degenerate primer designed based on the common sequence, cDNAs encoding those proteins were screened from a cDNA library of A. sydneiensis samea vanadocytes [18] . As a result, we obtained two similar, though slightly different, clones predicted to encode mature proteins of 221 amino acids (Fig. 2) . The predicted amino acid sequences were compared with known protein sequences registered in public protein databases using the program BLASTP and were revealed to have ≈50% similarity with theta-class GSTs of insects and mammals. Therefore, they were designated AsGSTs (ascidian GSTs). The AsGST with the methionine at residue 9 was designated AsGST-I because the cDNAs encoding this protein constituted the majority of the screened cDNAs, and the AsGST with leucine at residue 9 was designated AsGST-II (Fig. 2) . AsGST-I and AsGST-II correspond to the peak
Purification of recombinant AsGST-I using a V(IV)-chelating column
For a functional assay of AsGSTs, an expression system for recombinant
AsGSTs was constructed in E. coli. Since the level of AsGST-II expression in E. coli was very low, we used the AsGST-I expression system. Recombinant AsGST-I was specifically absorbed to a V(IV)-chelating column, and the absorbed fraction could be eluted with 100 mM NaCl (Fig. 3 , lane 5), indicating that AsGST-I clearly binds to V(IV) ions, but the affinity was weak. When recombinant AsGST-I was subject to HPLC, a single peak was eluted at 55 min (data not shown). The elution time corresponded to that of native AsGST-I (Fig.1B) .
On SDS-PAGE, recombinant
AsGST-I migrated with native AsGST-I (Fig. 3, lanes 5 and 7) . These results indicate that the recombinant AsGST-I corresponds to native AsGST-I.
Characterization of AsGST-I as a GST enzyme
First, we examined whether AsGST-I has enzymatic activity using CDNB as a substrate. A significantly higher level of activity was detected in lysate prepared from E. coli cells expressing AsGST-I than in lysate prepared from control cells bearing the empty vector (Fig. 4A) , indicating that AsGST-I acts as a GST enzyme.
As GSTs are known to form dimers [24] , we examined whether AsGST-I formed a dimer using the purified AsGST-I recombinant protein.
AsGST-I was subjected to gel-filtration chromatography, and the elution pattern was compared to that of low-molecular-weight marker proteins. As shown in Fig. 4B , the elution peak of AsGST-I was detected fraction No.29 which was immediately after the elution peak of a 45-kDa marker protein. If AsGST-I was a monomer, the peak should be detected after fraction No. 34 because the molecular weight of the AsGST-I subunit is 25.6 kDa.
Therefore, AsGST-I may form a dimer although the estimated size of the dimer was 40.7kDa that is smaller than the calculated size of 51.2 kDa (Fig. 4B inset) .
Vanadium-binding assay of AsGST-I
To assess the vanadium-binding ability of AsGST-I, the Hummel-Dreyer method was used [22] . Measurements were made using solutions of free V(IV) or V(V) ions ranging from 10 to 100 μM. The recombinant AsGST-I bound with both oxidation states of vanadium (Fig. 5A ). Scatchard plot analysis of the data revealed (Fig. 5B) . These values suggest that AsGST-I binds to both oxidation states of vanadium ion with weak affinity. These results demonstrate that
AsGST-I not only has characteristics of a GST enzyme, but also the novel property of vanadium-binding activity, which likely leads to the vanadium accumulation in ascidians.
Localization analysis of AsGSTs
To examine in which organs or tissues AsGSTs are localized, an immunological analysis was conducted using antiserum to AsGST-I (Fig. 6) .
Homogenates of the digestive system, body wall, endostyle, branchial sac, and blood cells prepared from adult individuals of A. sydneiensis samea were used in Western blot analysis. Purified AsGST-I recombinant protein was used as a positive control.
As result, AsGSTs were detected from all of the organs and tissues examined, and very dense bands due to AsGSTs were detected from the digestive system (Fig. 6B, lane1, arrowhead), which suggests that AsGSTs play an especially important role in the digestive system.
Discussion
The study of the mechanism of vanadium accumulation by ascidians has attracted interdisciplinary attention over the century since its discovery [1] . However, the mechanism and physiological significance of vanadium accumulation in ascidians remain poorly understood. In this decade, we have introduced biochemical and molecular biological methods to the investigation of these questions and have succeeded in identifying various key factors [2, 7-15, 18, 19] . For example,
Vanabins that are expressed strongly in vanadocytes and blood plasma of vanadium-accumulating ascidians play important roles in vanadium accumulation [13-15, 18, 19] .
In contrast, few studies have examined the pathway of vanadium accumulation from seawater into the ascidian coelom. In this study, novel vanadium-binding proteins with striking homology to GSTs, named AsGST-I and AsGST-II, were isolated from the digestive system for the first time using V(IV)-chelating column chromatography ( Figs. 1 and 2 ). GSTs are a superfamily of enzymes that utilize glutathione (GSH) in reactions contributing to the detoxification of a wide range of toxic compounds. GSTs are found in all eukaryotes and have various functions [24] .
Notwithstanding their versatility, GSTs have never been considered to be involved in metal homeostasis. Using AsGST-I recombinant protein, we have demonstrated that
AsGST-I forms a dimer, as do other GSTs (Fig. 4B) , and that it not only has GST activity ( Fig. 4A ), but it also has vanadium-binding activity (Fig. 5) . These activities could not be examined in AsGST-II because it was impossible to obtain sufficient recombinant protein due to the low expression level of AsGST-II in E. coli. However, since there is only a 5% difference in the amino acid sequences of AsGST-I and
AsGST-II (Fig. 2) , we believe that these proteins have similar characteristics and functions. AsGSTs were the most strongly expressed proteins in the digestive system (Fig. 1A) , and the expression there was much higher than in the other organs and tissues (Fig. 6) . Therefore, it is very likely that AsGSTs play an important role in the digestive system of ascidians.
We Vanabins. In addition, the expression of AsGSTs in the digestive system was considerably higher than in the other organs and tissues ( Fig. 6 ) and was comparable to that of Vanabins in the blood cells (Fig. 6A, lane5 , asterisk) [13] [14] [15] . Therefore,
AsGSTs may play an alternative role as a vanadium carrier protein in the digestive system, although further study of its function is required.
In seawater, vanadium is in the +5 oxidation state, while in ascidians, almost all the vanadium is reduced to the +3 oxidation state via the +4 oxidation state and is stored in the vacuoles of the vanadocytes [4] [5] [6] . During this process, NADPH produced by the pentose phosphate pathway localized in the vanadocyte cytoplasm is likely involved in the reduction of V(V) to V(IV) [7] [8] [9] [10] 28] . However, the compound reducing V(IV) to V(III) has not been identified in ascidians.
Nevertheless, there is no doubt that the accumulation of vanadium by ascidians is inevitably intertwined with the reduction of vanadium. One function of GSTs is to promote the conjugation of GSH to the electrophilic center of toxic compounds [24] , and GSH, the cofactor of GSTs, reduces V(V) to V(IV) and may act as a ligand for the generated V(IV) [29] . Recently Further, Gtt2 (a yeast GST) [31] and hGSTP1-1 (human GST Pi class) [32] were suggested to participate in the conjugation of GSH to cadmium and arsenic, which results in the production of GSH-complexes with cadmium [Cd(GS) 2 ] and arsenic
[As(GS) 3 ], respectively. Therefore, we hypothesize that AsGSTs may directly or indirectly be involved in the reduction of V(V) to V(IV) and the conjugation of V (IV) with GSH in the digestive system and the possibility should be examined in future.
Based on the results of our experiments, it is likely that the main function of
AsGSTs in the vanadium-accumulating process is vanadium-carrier in the digestive system. Vanadium ions taken up by ascidians via the digestive system might be captured by AsGSTs, vanadium-binding proteins that are locally abundant. Since
AsGSTs might be one of the first molecules involved in the influx of vanadium ions through the digestive system, these seem to be a quite important clue to elucidate the first step of the 10 million-fold vanadium-accumulating process in ascidians. AsGSTs were detected in all specimens (arrowhead). The expression in the digestive system was exceptionally high and rivaled the level of Vanabins in blood cells (asterisk).
Figure legends
